干燥综合征的癌症风险:一项关于发病率、预测因素和死亡影响的纵向队列研究
这项前瞻性多中心研究纳入314例符合2002年美国-欧洲共识小组标准的临床诊断干燥综合征患者,中位随访9.5年,发现总体癌症风险升高(SIR 1.68),主要源于血液系统恶性肿瘤(SIR 3.55),均为非霍奇金淋巴瘤,实体瘤风险中度升高(SIR 1.54);癌症占死亡原因的23.8%(RR 2.21,EFE 55%),独立预测因素包括高龄、吸烟、淋巴结肿大、脾肿大和冷球蛋白血症。
要点
- 干燥综合征患者总体癌症风险升高,SIR为1.68(95%CI 1.68-1.69)。
- 血液系统恶性肿瘤风险显著升高(SIR 3.55,95%CI 3.54-3.56),均为非霍奇金淋巴瘤。
- 癌症是重要死亡原因,占死亡23.8%(RR 2.21,EFE 55%)。
核心结论
- 干燥综合征患者恶性肿瘤风险升高,主要由非霍奇金淋巴瘤驱动,实体瘤风险中度升高,恶性肿瘤是死亡的重要贡献因素。
研究设计与样本
- 前瞻性多中心研究,纳入314例临床诊断干燥综合征且符合2002年美国-欧洲共识小组标准的患者,中位随访9.5年,收集临床、人口学和血清学数据及恶性肿瘤发病和死亡结局,采用GLOBOCAN数据计算标准化发病率比(SIR),多因素Cox回归识别恶性肿瘤预测因素,并评估死亡相对风险(RR)和暴露个体病因分数(EFE)。
主要发现
- 共发现22例恶性肿瘤(7.01%),其中血液系统恶性肿瘤11例(50%),实体瘤11例(50%)。
- 总体癌症风险升高(SIR 1.68,95%CI 1.68-1.69),血液系统恶性肿瘤风险显著升高(SIR 3.55,95%CI 3.54-3.56),实体瘤风险中度升高(SIR 1.54,95%CI 1.53-1.55)。
- 所有血液系统恶性肿瘤均为非霍奇金淋巴瘤。
- 恶性肿瘤的独立预测因素包括高龄、吸烟、淋巴结肿大、脾肿大和冷球蛋白血症。
- 癌症占死亡原因的23.8%(RR 2.21,EFE 55%)。
临床怎么用
- 作者认为这些发现强调需要对高危干燥综合征患者进行更好的风险分层和针对性监测,以实现早期发现和干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to evaluate standardized incidence ratios (SIRs) of overall malignancies, hematologic malignancies and solid tumors in patients with Sjögren's disease (SjD) compared to the general population. Furthermore, it sought to identify independent predictors of malignancy and quantify the impact of cancer on mortality. METHODS: This prospective, multicenter study included 314 patients clinically diagnosed with SjD and fulfilling 2002 American-European Consensus Group criteria, with a median follow-up of 9.5 years. Clinical, demographic, and serological data were collected, along with malignancy incidence and mortality outcomes. SIRs were calculated using GLOBOCAN data. Multivariate Cox regression identified malignancy predictors. The relative risk (RR) of death and the etiologic fraction in exposed individuals (EFE) assessed cancer-related mortality. RESULTS: A total of 22 malignancies (7.01%) were identified, including 11 hematologic malignancies (50%) and 11 solid tumors (50%). The overall cancer risk was increased (SIR: 1.68, 95% CI: 1.68-1.69), with a substantially higher risk for hematologic malignancies (SIR: 3.55, 95% CI: 3.54-3.56) and a moderate increase for solid tumors (SIR: 1.54, 95% CI: 1.53-1.55). All hematologic malignancies were non-Hodgkin lymphomas (NHL). Independent predictors of malignancy included older age, smoking, lymphadenopathy, splenomegaly, and cryoglobulinemia. Cancer was responsible for 23.8% of deaths (RR: 2.21, EFE: 55%). CONCLUSIONS: Patients with SjD have an elevated malignancy risk, mainly driven by NHL, while solid tumor risk remains modest. Malignancy was a significant contributor to mortality. These findings underscore the need for better risk stratification and targeted surveillance in high-risk SjD patients for early detection and intervention.
引用
- Rusinovich-Lovgach O, Plaza Z, Castro MF, et al. Cancer risk in Sjögren's disease: A longitudinal cohort study on incidence, predictors, and mortality impact. Semin Arthritis Rheum. 2025. PMID: 40349421. doi:10.1016/j.semarthrit.2025.152743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。